Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from Sirolimus to Everolimus in Renal Transplant Patients
NCT00170820Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in kidney transplantation, sponsored by Novartis. Primary endpoint: Renal function (glomerular filtration and tubular function) at 6 months. Started Feb 2005; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00170820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170820.